AVITA Medical (RCEL) Cost of Revenue (2018 - 2025)

AVITA Medical has reported Cost of Revenue for 8 years, with the latest figure at $43.6 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 1814.39% year-over-year to $43.6 million; the trailing twelve-month figure through Dec 2025 stood at $53.1 million (up 128.2% YoY), and the FY2025 full-year result was $53.1 million, up 484.32% from the prior year.
• Cost of Revenue for Q4 2025 stood at $43.6 million, up from $3.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $43.6 million in Q4 2025, with the low at $1.1 million in Q3 2021.
• Historically, Cost of Revenue has averaged $6.7 million across 5 years, with a median of $3.2 million in 2024.
• The largest YoY upside for Cost of Revenue was 1814.39% in 2025 against a maximum downside of 78.72% in 2025.
• AVITA Medical's Cost of Revenue stood at $1.1 million in 2021, then jumped by 482.9% to $6.3 million in 2022, then surged by 61.08% to $10.2 million in 2023, then tumbled by 77.68% to $2.3 million in 2024, then soared by 1814.39% to $43.6 million in 2025.
• The last three Cost of Revenue figures came in at $43.6 million (Q4 2025), $3.2 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.